Aina Marti Carretero

Institutions of which they are part

Predoctoral researcher
Liver Diseases

Vall Hebron Institut de Recerca

Aina Marti Carretero

Institutions of which they are part

Predoctoral researcher
Liver Diseases

Vall Hebron Institut de Recerca

Related news

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.